ST3GAL5 Antibody

Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. The protein encoded by this gene is a type II membrane protein which catalyzes the formation of GM3 using lactosylceramide as the substrate. The encoded protein is a member of glycosyltransferase family 29 and may be localized to the Golgi apparatus. Mutation in this gene has been associated with Amish infantile epilepsy syndrome. Transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 1 application: WB.

Showing Publications 1 - 2 of 2.

Publications using NBP2-20492	Applications	Species
Zhang J, van der Zon G, Ma J et al. ST3GAL5-catalyzed gangliosides inhibit TGF-b-induced epithelial-mesenchymal transition via TbRI degradation The EMBO journal 2022-12-12 [PMID: 36504224] (WB, Mouse, Human) Details: Dilution used in WB 1:1000	WB	Mouse, Human
Kurcon T, Liu Z, Paradkar AV et al. miRNA proxy approach reveals hidden functions of glycosylation. Proc. Natl. Acad. Sci. U.S.A. 2015-05-26 [PMID: 26015571] (WB, Human)	WB	Human

Array NBP2-20492

• ST3GAL5 Antibodies
• ST3GAL5 Lysate
• ST3GAL5 Proteins
• ST3GAL5 Proteins and Enzyme